Sourcing Portfolio

Clinical Modalities & Sourcing Portfolio

Suisse Beaute SA consults with private medical centres across Asia-Pacific to expand and refine their preventative-medicine offerings. We do not stock a catalogue of products; we engineer therapeutic pipelines. Each modality below is actively sourced from manufacturers we have personally audited, then matched to the clinical context, patient demographics, and regulatory environment of the partner clinic. The result is a curated, defensible portfolio of advanced longevity interventions — delivered with Swiss discretion.

Bioidentical Hormone Replacement Therapy

We focus on advanced, extended-release subcutaneous pellet therapies for precision endocrine optimisation. We partner exclusively with world-class manufacturers maintaining state-of-the-art automation, rigorous quality control, and pristine compounding standards.

Hormonal decline is one of the most modifiable drivers of biological aging, yet remains under-served in much of the APAC private-medical market. Pellet-based BHRT delivers steady-state physiological dosing over three to six months, eliminating the peak-and-trough volatility of creams and injections. We help partner clinics build the diagnostic intake, dosing logic, and longitudinal follow-up required to operate BHRT to a Swiss standard of care.

Plant-derived, molecularly identical estradiol and testosterone pellet formulations
Dose-titration protocols guided by serum and salivary biomarker panels
cGMP 503B-compliant compounding partners with full chain-of-custody traceability
Clinician training pathways for in-office insertion and patient follow-up cadence
Adverse-event review protocols and dose-recalibration playbooks

Cellular research in a modern biotech laboratory

Cellular Longevity & Metabolic Optimisation

We supply private clinical networks with specialised, evidence-based nutraceuticals, advanced biomarker tracking, and preventative metabolic protocols engineered around long-term healthspan.

The next decade of longevity medicine will be defined by what clinicians can measure. We help partner clinics move beyond surface-level wellness panels and into actionable cellular-aging data — combining DNA-methylation clocks, inflammatory load, glycan profiles, and continuous metabolic markers into a single longitudinal patient view. Each intervention is paired with a measurement strategy, so progress is demonstrable and protocols can be refined cycle by cycle.

NAD+ precursor and senolytic protocols sourced from peer-reviewed supply lines
Epigenetic and biological-age testing (DNA methylation, GlycanAge, inflammatory load)
Continuous metabolic monitoring integrated with clinician dashboards
Personalised peptide and micronutrient protocols for mitochondrial resilience
Quarterly biomarker reviews benchmarked against age-matched cohorts

Tranquil Swiss alpine wellness clinic interior

Swiss Anti-Aging Frameworks

We implement high-end wellness frameworks designed to optimise healthspan, vitality, and cellular defence mechanisms — drawing on Switzerland's tradition of preventative medicine.

Switzerland has refined the discipline of preventative medicine over more than a century — from alpine sanatoria to contemporary cellular-therapy clinics. We translate that heritage into structured, repeatable frameworks that a private APAC clinic can adopt without rebuilding its operating model. The emphasis is on annual cadence, member-grade hospitality, and a defensible standard of evidence behind every recommendation.

Clinic-grade preventative cardiology and metabolic screening intake
Curated Swiss-origin nutraceutical and cosmeceutical formularies
Member-care frameworks adapted for APAC private medical networks
Annual healthspan reviews benchmarked against Swiss longevity standards
Concierge coordination between the partner clinic and Swiss reference centres

Sourcing Standards

Every modality is filtered through a Swiss-grade diligence process.

We will not introduce a therapy into a partner clinic until it has cleared our internal review across four dimensions. This is the discipline our manufacturers and practitioner networks rely on.

Regulatory provenance

Manufacturer licensing, inspection history, and jurisdictional approvals reviewed end-to-end.

Scientific evidence

Peer-reviewed clinical literature and outcome data assessed before clinical onboarding.

Compounding integrity

Facility audits covering automation, sterility, batch records, and chain-of-custody.

Clinical fit

Protocols matched to each partner clinic's patient profile, workflow, and regulatory context.

Engagement Process

How we onboard a new modality.

Discovery & scoping

Confidential intake call to align on therapeutic gap, patient cohort, and regulatory environment.

Manufacturer vetting

Cross-border diligence across regulatory, scientific, and operational criteria.

Clinical onboarding

Protocol design, clinician training, and supply-chain activation into the partner clinic.

Continuous review

Outcome tracking, batch verification, and ongoing regulatory monitoring.

Manufacturers and licensed practitioners are invited to initiate a confidential conversation.

Contact →